Format

Send to

Choose Destination
Infection. 2017 Apr;45(2):215-220. doi: 10.1007/s15010-016-0976-x. Epub 2017 Jan 4.

Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort study.

Author information

1
Institute of Health Informatics, University College London, London, UK. c.warren-gash@ucl.ac.uk.
2
The Farr Institute of Health Informatics Research, 222 Euston Road, London, NW1 2DA, UK. c.warren-gash@ucl.ac.uk.
3
Institute of Liver Studies, King's College Hospital, London, UK.
4
Research Department of Infection and Population Health, University College London, London, UK.
5
Department of Infectious Diseases, Royal Free London NHS Foundation Trust, London, UK.
6
Institute for Liver and Digestive Health, Division of Medicine, University College London, London, UK.
7
Hepatology Unit, Department of Experimental and Clinical Medicine, University of Catania, Catania, Italy.
8
Regional Infectious Diseases Unit, Western General Hospital, Edinburgh, UK.

Abstract

This study assessed the likelihood of referral for liver transplantation assessment in a prospective cohort of patients co-infected with HIV and hepatitis B or C with complications of cirrhosis. There were 141 co-infected patients from 11 UK centres with at least one complication of cirrhosis recorded (either decompensation or hepatocellular carcinoma) out of 772 identified with cirrhosis and/or HCC. Only 23 of these 141 (16.3%) were referred for liver transplantation assessment, even though referral is recommended for co-infected patients after the first decompensation episode.

KEYWORDS:

Cirrhosis; Co-infection; HIV; Hepatitis B; Hepatitis C; Liver transplantation

PMID:
28054251
PMCID:
PMC5374166
DOI:
10.1007/s15010-016-0976-x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center